Christopher F.  Wyatt net worth and biography

Christopher Wyatt Biography and Net Worth

Chris Wyatt is senior vice president and controller for Nashville, Tennessee-based HCA Healthcare, one of the nation’s leading providers of healthcare services. His responsibilities include Financial Reporting, Corporate Accounting, Reimbursement, Tax and HCA Healthcare’s Insurance subsidiary, HCI.

Previously, Wyatt served as the chief financial officer for HCA Healthcare Information Technology and Services where he provided financial, contractual and portfolio leadership. Prior to that role, Wyatt served as CFO for HCA Healthcare’s Clinical Services Group. As the CSG CFO, he provided financial leadership for the company’s meaningful use and electronic health record initiatives.

Before joining HCA Healthcare, Wyatt was with Ernst & Young for ten years. During that time, he worked with clients in the healthcare industry, including HCA Healthcare.

Wyatt currently serves on the board of Monroe Harding, a non-profit supporting foster care youth and other vulnerable young people. He also serves on the Tennessee State University Accounting Advisory Board.

Wyatt holds Bachelor’s Degrees in Accounting and Finance from the University of Tennessee and is a Certified Public Accountant.

What is Christopher F. Wyatt's net worth?

The estimated net worth of Christopher F. Wyatt is at least $13.47 million as of July 29th, 2024. Mr. Wyatt owns 40,449 shares of HCA Healthcare stock worth more than $13,469,517 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Wyatt may own. Learn More about Christopher F. Wyatt's net worth.

How do I contact Christopher F. Wyatt?

The corporate mailing address for Mr. Wyatt and other HCA Healthcare executives is ONE PARK PLAZA, NASHVILLE TN, 37203. HCA Healthcare can also be reached via phone at (615) 344-9551 and via email at [email protected]. Learn More on Christopher F. Wyatt's contact information.

Has Christopher F. Wyatt been buying or selling shares of HCA Healthcare?

Christopher F. Wyatt has not been actively trading shares of HCA Healthcare in the last ninety days. Most recently, Christopher F. Wyatt sold 4,000 shares of the business's stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a transaction totalling $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares of the company's stock, valued at $14,569,729.80. Learn More on Christopher F. Wyatt's trading history.

Who are HCA Healthcare's active insiders?

HCA Healthcare's insider roster includes Erol Akdamar (Insider), Jennifer Berres (SVP), Phillip Billington (SVP), Jeffrey Cohen (SVP), Michael Cuffe (Insider), Jane Englebright (SVP), Jon Foster (Insider), Thomas Frist, Jr. (Major Shareholder), Charles Hall (Insider), Samuel Hazen (CEO & Director), Michael McAlevey (SVP), Timothy McManus (Insider), Sandra Morgan (SVP), A. Morre, Jr. (Insider), Sammie Mosier (Senior Vice President and Chief Nurse Executive), P. Paslick (SVP), Jonathan Perlin (CMO), Deborah Reiner (SVP), Wayne Riley (Director), Bill Rutherford (CFO), William Rutherford (Exec. VP & CFO ), Andrea Smith (Director), Joseph Sowell, III (SVP), Kathryn Torres (SVP), Chad Wasserman (SVP), Robert Waterman (SVP), Kathleen Whalen (SVP), and Christopher Wyatt (SVP). Learn More on HCA Healthcare's active insiders.

Are insiders buying or selling shares of HCA Healthcare?

During the last twelve months, insiders at the sold shares 18 times. They sold a total of 51,236 shares worth more than $17,305,720.38. The most recent insider tranaction occured on November, 14th when SVP Phillip G Billington sold 3,897 shares worth more than $1,363,950.00. Insiders at HCA Healthcare own 1.7% of the company. Learn More about insider trades at HCA Healthcare.

Information on this page was last updated on 11/14/2024.

Christopher F. Wyatt Insider Trading History at HCA Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/29/2024Sell4,000$360.20$1,440,800.0040,449View SEC Filing Icon  
2/1/2023Sell4,900$253.30$1,241,170.0032,392View SEC Filing Icon  
5/4/2021Sell4,604$204.00$939,216.0027,747View SEC Filing Icon  
2/19/2021Sell3,200$177.06$566,592.0033,740View SEC Filing Icon  
10/30/2019Sell3,900$134.74$525,486.0027,353View SEC Filing Icon  
11/7/2016Sell3,152$79.00$249,008.007,558View SEC Filing Icon  
See Full Table

Christopher F. Wyatt Buying and Selling Activity at HCA Healthcare

This chart shows Christopher F Wyatt's buying and selling at HCA Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HCA Healthcare Company Overview

HCA Healthcare logo
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $333.00
Low: $327.88
High: $335.61

50 Day Range

MA: $381.99
Low: $333.00
High: $415.67

2 Week Range

Now: $333.00
Low: $245.84
High: $417.14

Volume

1,426,476 shs

Average Volume

1,690,952 shs

Market Capitalization

$84.35 billion

P/E Ratio

14.95

Dividend Yield

0.79%

Beta

1.68